Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$19.05 - $28.32 $4.57 Million - $6.8 Million
-240,000 Closed
0 $0
Q1 2021

May 13, 2021

SELL
$11.86 - $21.77 $770,900 - $1.42 Million
-65,000 Reduced 21.31%
240,000 $4.38 Million
Q4 2020

Feb 12, 2021

SELL
$7.25 - $11.76 $181,250 - $294,000
-25,000 Reduced 7.58%
305,000 $3.52 Million
Q2 2020

Aug 10, 2020

SELL
$4.11 - $6.78 $123,300 - $203,400
-30,000 Reduced 8.33%
330,000 $2.17 Million
Q3 2018

Nov 14, 2018

SELL
$4.28 - $7.32 $492,200 - $841,800
-115,000 Reduced 24.21%
360,000 $2.47 Million
Q1 2018

May 10, 2018

BUY
$2.32 - $4.22 $1.1 Million - $2 Million
475,000 New
475,000 $1.39 Million

Others Institutions Holding CDMO

About Avid Bioservices, Inc.


  • Ticker CDMO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,167,500
  • Market Cap $762M
  • Description
  • Avid Bioservices, Inc., a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. The company produces monoclonal antibodies and recombinant pro...
More about CDMO
Track This Portfolio

Track Schwartz Investment Counsel Inc Portfolio

Follow Schwartz Investment Counsel Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Schwartz Investment Counsel Inc, based on Form 13F filings with the SEC.

News

Stay updated on Schwartz Investment Counsel Inc with notifications on news.